`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`ARGENTUM PHARMACEUTICALS LLC
`Petitioner
`
`v.
`
`CIPLA LTD.
`Patent Owner
`
`Patent No. 8,168,620
`Issue Date: May 1, 2012
`Title: COMBINATION OF AZELASTINE AND STEROIDS
`_______________
`
`Inter Partes Review No. IPR2017-00807
`
`STIPULATION CONCERNING SCHEDULE
`
`
`
`Petitioner ARGENTUM PHARMACEUTICALS LLC and Patent Owner
`
`CIPLA LTD. have conferred, and hereby stipulate and agree as follows:
`
`1. Due Date 2 is extended to March 6, 2018.
`
`Dated: February 2, 2018
`
`By: /Michael R. Houston/
`
`Michael R. Houston
`Reg. No. 58,486
`Counsel for Petitioner
`
`2
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing
`
`STIPULATION CONCERNING SCHEDULE was served on February 2, 2018
`
`on Counsel for Patent Owner via electronic mail to the following:
`
`dvarughe-PTAB@skgf.com
` dsterlin-PTAB@skgf.com
` alarock-PTAB@skgf.com
` ueverett-PTAB@skgf.com
`
`Dated: February 2, 2018
`
`By: /Michael R. Houston/
`
`Michael R. Houston
`Reg. No. 58,486
`Counsel for Petitioner
`
`3
`
`